CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and ...

Blue Water Biotech—which changed its name from Blue Water Vaccines this May after buying FDA-approved benign prostatic hyperplasia (BPH) drug Entadfi from Veru—is deprioritizing all vaccine ...

Downtown-headquartered Blue Water Vaccines, a biotech company developing a universal flu vaccine, among other candidates, opened at $59.02 and closed at $10.17, a 82.77% price drop.

In recent months, Blue Water Biotech, Inc. (“Blue Water”) has evolved from a preclinical vaccine development company to a commercial stage pharmaceutical company after the purchase of several ...